title: [Effects of drug adherence on patient outcomes to early treatment for Japanese cedar pollinosis].
abstract: Drug adherence is one of the important aspects in caring for patients with allergic rhinitis. To improve clinical efficacy of early treatment for Japanese cedar pollinosis (JCP), we evaluated the effect of drug adherence on patients' outcomes. Patients were randomly selected from 16 ENT clinical sites in Osaka and Wakayama between February 24 and March 8, 2003 (peak pollen season). Efficacy was assessed using patients' ratings of nasal and ocular symptoms and overall assessment in their condition compared with previous season ones. Costs include direct costs of the drugs used for treatment to JCP from January to February. Five hundred one patients taking early treatment were enrolled. Compared to low adherence patients, those who reported higher level of adherence significantly improved overall health condition, and achieved better symptom relief of rhinorrhea and nasal congestion. In multiple logistic regression analysis, the following factors were independent risk factors for low adherence: student (p=0.002), using OTC medications (p=0.006), and short-duration of medication (p=0.001). Low costs were also risk factor for low adherence. We conclude that taking medications for JCP for 22-28 days is the best way to enhance patients' outcomes.
authors.affiliation: School of Allied Health Sciences, Faculty of Medicine, Osaka University.
authors.forename: Chieko
authors.initials: C
authors.lastname: Kakutani
authors.forename: Satoshi
authors.initials: S
authors.lastname: Ogino
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Dake
authors.forename: Hiroki
authors.initials: H
authors.lastname: Ikeda
authors.forename: Tadao
authors.initials: T
authors.lastname: Enomoto
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D032485:Cryptomeria; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011058:Pollen; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D016896:Treatment Outcome